The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting

Molecular Reproduction and Development

Volumn 74, Issue 11, 2007, Pages 1483-1489

  Rawles, Lesli Ann ^a,b   Acuna, Diana ^a   Erickson, Robert P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

6 aminonicotinamide; Cleft lip; Cleft palate; Hydrocortisone; P glycoproteins; Phenylhydantoin; Placenta

Indexed keywords

6 AMINONICOTINAMIDE; GLYCOPROTEIN P; HYDROCORTISONE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; MULTIDRUG RESISTANCE PROTEIN 2; PHENYTOIN; TERATOGENIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEFT FACE; CLEFT LIP FACE PALATE; CONGENIC STRAIN; CONTROLLED STUDY; FACE MALFORMATION; FEMALE; FETUS; FETUS DEVELOPMENT; GENETIC CROSS; GENETIC SUSCEPTIBILITY; INCIDENCE; KNOCKOUT MOUSE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CROSSING OVER, GENETIC; DRUG RESISTANCE, MULTIPLE; EAR; FACE; FEMALE; FETUS; MICE; MICE, KNOCKOUT; P-GLYCOPROTEINS; PLACENTA; PREGNANCY; TERATOGENS;

EID: 34748820749     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20734     Document Type: Article

References (28)

1. Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M. 1998. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337-5339.
2. Arceci RJ, Croop JM, Horwitz SB, Housman D. 1988. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci 85:4350-4354.
3. Borst P, Elferink R. 2002. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-592.
4. Cordon-Carlo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR. 1990. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277-1287.
5. Croop J, Raymond M, Haber D, Devault A, Arceci R, Gros P, Housman D. 1989. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9:1346-1350.
6. Greenberger LM, Croop JM, Horwitz SB, Arceci RJ. 1989. P-glycoproteins encoded by mdr1b in murine gravid uterus and multidrug resistant tumor cell lines are differentially glycosylated. FEBS Lett 257:419-421.
7. Juriloff DM, Fraser FC. 1980. Genetic maternal effects on cleft lip frequency in A/J and CL/FR mice. Teratology 21:167-175.
8. Karolyi J, Erickson RP, Liu S, Killewald L. 1990. Major effects on teratogen-inuduced facial clefting in mice determined by a single genetic region. Genetics 126:201-205.
9. Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR. 1998. Placental P-glycoproteins deficiency enhances susceptibility to chemically linked induced birth defects in mice. Reprod Toxicol 12: 457-464.
10. MacFarland A, Abramovich DR, Ewen SWB, Pearson CK. 1994. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem J 26:417-423.
11. Martin DA, Nonaka K, Yanagita K, Nakata M. 1995. The effect of dam strain on the craniofacial morphogenesis of CL/Fr mouse fetuses. J Craniofac Genet Dev Biol 15:117-124.
12. Mylona P, Glazier JD, Greenwood SL, Sides MK, Sibley CP. 1996. Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol Human Reprod 2:693-698.
13. Nakamura Y, Shun-ichi I, Furukawa T, Sumizawa T, Tani A, Akiyama S, Nagata Y. 1997. Functions of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun 235:849-853.
14. Nonaka K, Sasaki Y, Watanabe Y, Yanagita K, Nakata M. 1997. Effects of fetus weight, dam strain, dam weight, and litter size on craniofacial morphogenesis of CL/Fr mouse fetuses affected with cleft lip and palate. Cleft Palate Craniofac J 34:325-330.
15. Oude Elferink RPJ, Tytgat GNJ, Groen AK, 1997. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J 11:19-28.
16. Pacifici GM, Bencini C, Rane A. 1986. Acetyltransferases in humans: Development and tissue distribution. Pharmacology 32:283-91.
17. Pascolo L, Fernetti C, Garcia-Mediavilla MV, Ostrow JD, Tiribelli C. 2001. Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo cells. FEBS Lett 495:94-99.
18. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P. 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
19. Schinkel AH, Agenaar E, Van Deemter L, Borst P. 1995. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clinical Invest 96:1698-1705.
20. Schinkel AH, Mayer U, Wagenaar E, Mol CAAM, Van Deemter L, Smit JJ, Van Der Valk MA, Voordouw AC, Spits H, Van Tellingen O, Zijlmans JM, Fibbe WE, Borst P. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033.
21. Smit JJ, Schinkel AH, Oude Elferink RPL, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhof R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM, Borst P. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451-462.
22. Smit J, Huisman M, Tellingen O, Wiltshire H, Schinkel A. 1999. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 104:1441-1447.
23. St-Pierre MV, Serrano MA, Macias RIR, Dubs U, Hoechli M, Lauper U, Meier PJ, Marin JJG. 2000. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279:R1495-R1503.
24. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W. 2006. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27:602-609.
25. Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y, Takahashi M, Kurata Y, Kigawa J, Higuchi S, Terakawa N, Otsubo K. 2001. Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297:1137-1143.
26. Ushigome F, Takanaga H, Matsuo H, Yanai S, Tsukimori K, Nakano H, Uchiumi T, Nakamura T, Kuwano M, Ohtani H, Sawada Y. 2000. Human placental transport of vinblastine, vincristine, digoxin and progesterone: Contribution of P-glycoprotein. Eur J Pharmacol 408: 1-10.
27. Utoguchi N, Chandorkar GA, Avery M, Audus KL. 2000. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod Toxicol 14:217-224.
28. Young AM, Allen CE, Audus KL. 2003. Efflux transporters of the human placenta. Adv Drug Deliv Rev 55:125-132.